 | • レポートコード：MRC2-11QY11618 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はうつ病治療療法のグローバル市場について調査・分析したレポートです。種類別（医薬品、治療装置）市場規模、用途別（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、双極性障害）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別うつ病治療療法の競争状況、市場シェア ・世界のうつ病治療療法市場：種類別市場規模 2015年-2020年（医薬品、治療装置） ・世界のうつ病治療療法市場：種類別市場規模予測 2021年-2026年（医薬品、治療装置） ・世界のうつ病治療療法市場：用途別市場規模 2015年-2020年（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、双極性障害） ・世界のうつ病治療療法市場：用途別市場規模予測 2021年-2026年（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、双極性障害） ・北米のうつ病治療療法市場分析：米国、カナダ ・ヨーロッパのうつ病治療療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのうつ病治療療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のうつ病治療療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのうつ病治療療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Teva Pharmaceutical、Johnson and Johnson、Merck、Eli Lily、Novartis、Sanofi、AstraZeneca、Allergan、Mayo Clinic、Bristol-Myers Squibb、Takeda、Brainsway、Lundbeck、NeuroStar、Otsuka、VistaGen Therapeutics、Silver Oak Health、NeuroSigma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.
One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders is also driving the market.
Market Analysis and Insights: Global Depression Treatment Therapy Market
The global Depression Treatment Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Depression Treatment Therapy Scope and Market Size
Depression Treatment Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Depression Treatment Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Teva Pharmaceutical
Johnson and Johnson
Merck
Eli Lily
Novartis
Sanofi
AstraZeneca
Allergan
Mayo Clinic
Bristol-Myers Squibb
Takeda
Brainsway
Lundbeck
NeuroStar
Otsuka
VistaGen Therapeutics
Silver Oak Health
NeuroSigma
Market segment by Type, the product can be split into
Drugs
Treatment device
Market segment by Application, split into
Seasonal affective disorder (SAD)
Major depression
Dysthymia disorder
Postpartum depression
Atypical depression
Psychotic depression
Bipolar disorder
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Depression Treatment Therapy Revenue
1.4 Market by Type
1.4.1 Global Depression Treatment Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Treatment device
1.5 Market by Application
1.5.1 Global Depression Treatment Therapy Market Share by Application: 2020 VS 2026
1.5.2 Seasonal affective disorder (SAD)
1.5.3 Major depression
1.5.4 Dysthymia disorder
1.5.5 Postpartum depression
1.5.6 Atypical depression
1.5.7 Psychotic depression
1.5.8 Bipolar disorder
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Depression Treatment Therapy Market Perspective (2015-2026)
2.2 Global Depression Treatment Therapy Growth Trends by Regions
2.2.1 Depression Treatment Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Depression Treatment Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Depression Treatment Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Depression Treatment Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Depression Treatment Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Depression Treatment Therapy Players by Market Size
3.1.1 Global Top Depression Treatment Therapy Players by Revenue (2015-2020)
3.1.2 Global Depression Treatment Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Depression Treatment Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Depression Treatment Therapy Market Concentration Ratio
3.2.1 Global Depression Treatment Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Depression Treatment Therapy Revenue in 2019
3.3 Depression Treatment Therapy Key Players Head office and Area Served
3.4 Key Players Depression Treatment Therapy Product Solution and Service
3.5 Date of Enter into Depression Treatment Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Depression Treatment Therapy Historic Market Size by Type (2015-2020)
4.2 Global Depression Treatment Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Depression Treatment Therapy Market Size by Application (2015-2020)
5.2 Global Depression Treatment Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Depression Treatment Therapy Market Size (2015-2020)
6.2 Depression Treatment Therapy Key Players in North America (2019-2020)
6.3 North America Depression Treatment Therapy Market Size by Type (2015-2020)
6.4 North America Depression Treatment Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Depression Treatment Therapy Market Size (2015-2020)
7.2 Depression Treatment Therapy Key Players in Europe (2019-2020)
7.3 Europe Depression Treatment Therapy Market Size by Type (2015-2020)
7.4 Europe Depression Treatment Therapy Market Size by Application (2015-2020)
8 China
8.1 China Depression Treatment Therapy Market Size (2015-2020)
8.2 Depression Treatment Therapy Key Players in China (2019-2020)
8.3 China Depression Treatment Therapy Market Size by Type (2015-2020)
8.4 China Depression Treatment Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Depression Treatment Therapy Market Size (2015-2020)
9.2 Depression Treatment Therapy Key Players in Japan (2019-2020)
9.3 Japan Depression Treatment Therapy Market Size by Type (2015-2020)
9.4 Japan Depression Treatment Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Depression Treatment Therapy Market Size (2015-2020)
10.2 Depression Treatment Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Depression Treatment Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Depression Treatment Therapy Market Size by Application (2015-2020)
11 India
11.1 India Depression Treatment Therapy Market Size (2015-2020)
11.2 Depression Treatment Therapy Key Players in India (2019-2020)
11.3 India Depression Treatment Therapy Market Size by Type (2015-2020)
11.4 India Depression Treatment Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Depression Treatment Therapy Market Size (2015-2020)
12.2 Depression Treatment Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Depression Treatment Therapy Market Size by Type (2015-2020)
12.4 Central & South America Depression Treatment Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Depression Treatment Therapy Introduction
13.1.4 Pfizer Revenue in Depression Treatment Therapy Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Details
13.2.2 Teva Pharmaceutical Business Overview
13.2.3 Teva Pharmaceutical Depression Treatment Therapy Introduction
13.2.4 Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2015-2020)
13.2.5 Teva Pharmaceutical Recent Development
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Details
13.3.2 Johnson and Johnson Business Overview
13.3.3 Johnson and Johnson Depression Treatment Therapy Introduction
13.3.4 Johnson and Johnson Revenue in Depression Treatment Therapy Business (2015-2020)
13.3.5 Johnson and Johnson Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Depression Treatment Therapy Introduction
13.4.4 Merck Revenue in Depression Treatment Therapy Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Eli Lily
13.5.1 Eli Lily Company Details
13.5.2 Eli Lily Business Overview
13.5.3 Eli Lily Depression Treatment Therapy Introduction
13.5.4 Eli Lily Revenue in Depression Treatment Therapy Business (2015-2020)
13.5.5 Eli Lily Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Depression Treatment Therapy Introduction
13.6.4 Novartis Revenue in Depression Treatment Therapy Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Depression Treatment Therapy Introduction
13.7.4 Sanofi Revenue in Depression Treatment Therapy Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview
13.8.3 AstraZeneca Depression Treatment Therapy Introduction
13.8.4 AstraZeneca Revenue in Depression Treatment Therapy Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Allergan
13.9.1 Allergan Company Details
13.9.2 Allergan Business Overview
13.9.3 Allergan Depression Treatment Therapy Introduction
13.9.4 Allergan Revenue in Depression Treatment Therapy Business (2015-2020)
13.9.5 Allergan Recent Development
13.10 Mayo Clinic
13.10.1 Mayo Clinic Company Details
13.10.2 Mayo Clinic Business Overview
13.10.3 Mayo Clinic Depression Treatment Therapy Introduction
13.10.4 Mayo Clinic Revenue in Depression Treatment Therapy Business (2015-2020)
13.10.5 Mayo Clinic Recent Development
13.11 Bristol-Myers Squibb
10.11.1 Bristol-Myers Squibb Company Details
10.11.2 Bristol-Myers Squibb Business Overview
10.11.3 Bristol-Myers Squibb Depression Treatment Therapy Introduction
10.11.4 Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2015-2020)
10.11.5 Bristol-Myers Squibb Recent Development
13.12 Takeda
10.12.1 Takeda Company Details
10.12.2 Takeda Business Overview
10.12.3 Takeda Depression Treatment Therapy Introduction
10.12.4 Takeda Revenue in Depression Treatment Therapy Business (2015-2020)
10.12.5 Takeda Recent Development
13.13 Brainsway
10.13.1 Brainsway Company Details
10.13.2 Brainsway Business Overview
10.13.3 Brainsway Depression Treatment Therapy Introduction
10.13.4 Brainsway Revenue in Depression Treatment Therapy Business (2015-2020)
10.13.5 Brainsway Recent Development
13.14 Lundbeck
10.14.1 Lundbeck Company Details
10.14.2 Lundbeck Business Overview
10.14.3 Lundbeck Depression Treatment Therapy Introduction
10.14.4 Lundbeck Revenue in Depression Treatment Therapy Business (2015-2020)
10.14.5 Lundbeck Recent Development
13.15 NeuroStar
10.15.1 NeuroStar Company Details
10.15.2 NeuroStar Business Overview
10.15.3 NeuroStar Depression Treatment Therapy Introduction
10.15.4 NeuroStar Revenue in Depression Treatment Therapy Business (2015-2020)
10.15.5 NeuroStar Recent Development
13.16 Otsuka
10.16.1 Otsuka Company Details
10.16.2 Otsuka Business Overview
10.16.3 Otsuka Depression Treatment Therapy Introduction
10.16.4 Otsuka Revenue in Depression Treatment Therapy Business (2015-2020)
10.16.5 Otsuka Recent Development
13.17 VistaGen Therapeutics
10.17.1 VistaGen Therapeutics Company Details
10.17.2 VistaGen Therapeutics Business Overview
10.17.3 VistaGen Therapeutics Depression Treatment Therapy Introduction
10.17.4 VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2015-2020)
10.17.5 VistaGen Therapeutics Recent Development
13.18 Silver Oak Health
10.18.1 Silver Oak Health Company Details
10.18.2 Silver Oak Health Business Overview
10.18.3 Silver Oak Health Depression Treatment Therapy Introduction
10.18.4 Silver Oak Health Revenue in Depression Treatment Therapy Business (2015-2020)
10.18.5 Silver Oak Health Recent Development
13.19 NeuroSigma
10.19.1 NeuroSigma Company Details
10.19.2 NeuroSigma Business Overview
10.19.3 NeuroSigma Depression Treatment Therapy Introduction
10.19.4 NeuroSigma Revenue in Depression Treatment Therapy Business (2015-2020)
10.19.5 NeuroSigma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Depression Treatment Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Depression Treatment Therapy Revenue
Table 3. Ranking of Global Top Depression Treatment Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Depression Treatment Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Treatment device
Table 7. Global Depression Treatment Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Depression Treatment Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Depression Treatment Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Depression Treatment Therapy Market Share by Regions (2015-2020)
Table 11. Global Depression Treatment Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Depression Treatment Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Depression Treatment Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Depression Treatment Therapy Players
Table 18. Global Depression Treatment Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Depression Treatment Therapy Market Share by Players (2015-2020)
Table 20. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Treatment Therapy as of 2019)
Table 21. Global Depression Treatment Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Depression Treatment Therapy Product Solution and Service
Table 24. Date of Enter into Depression Treatment Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Depression Treatment Therapy Market Size Share by Type (2015-2020)
Table 28. Global Depression Treatment Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global Depression Treatment Therapy Market Size Share by Application (2015-2020)
Table 30. Global Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Depression Treatment Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Depression Treatment Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Depression Treatment Therapy Market Share (2019-2020)
Table 34. North America Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Depression Treatment Therapy Market Share by Type (2015-2020)
Table 36. North America Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Depression Treatment Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Depression Treatment Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Depression Treatment Therapy Market Share (2019-2020)
Table 40. Europe Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Depression Treatment Therapy Market Share by Type (2015-2020)
Table 42. Europe Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Depression Treatment Therapy Market Share by Application (2015-2020)
Table 44. China Key Players Depression Treatment Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Depression Treatment Therapy Market Share (2019-2020)
Table 46. China Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Depression Treatment Therapy Market Share by Type (2015-2020)
Table 48. China Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Depression Treatment Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Depression Treatment Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Depression Treatment Therapy Market Share (2019-2020)
Table 52. Japan Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Depression Treatment Therapy Market Share by Type (2015-2020)
Table 54. Japan Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Depression Treatment Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Depression Treatment Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Depression Treatment Therapy Market Share (2019-2020)
Table 58. Southeast Asia Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Depression Treatment Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Depression Treatment Therapy Market Share by Application (2015-2020)
Table 62. India Key Players Depression Treatment Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Depression Treatment Therapy Market Share (2019-2020)
Table 64. India Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Depression Treatment Therapy Market Share by Type (2015-2020)
Table 66. India Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Depression Treatment Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Depression Treatment Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Depression Treatment Therapy Market Share (2019-2020)
Table 70. Central & South America Depression Treatment Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Depression Treatment Therapy Market Share by Type (2015-2020)
Table 72. Central & South America Depression Treatment Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Depression Treatment Therapy Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Teva Pharmaceutical Company Details
Table 80. Teva Pharmaceutical Business Overview
Table 81. Teva Pharmaceutical Product
Table 82. Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 83. Teva Pharmaceutical Recent Development
Table 84. Johnson and Johnson Company Details
Table 85. Johnson and Johnson Business Overview
Table 86. Johnson and Johnson Product
Table 87. Johnson and Johnson Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 88. Johnson and Johnson Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Eli Lily Company Details
Table 95. Eli Lily Business Overview
Table 96. Eli Lily Product
Table 97. Eli Lily Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 98. Eli Lily Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 108. Sanofi Recent Development
Table 109. AstraZeneca Business Overview
Table 110. AstraZeneca Product
Table 111. AstraZeneca Company Details
Table 112. AstraZeneca Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 113. AstraZeneca Recent Development
Table 114. Allergan Company Details
Table 115. Allergan Business Overview
Table 116. Allergan Product
Table 117. Allergan Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 118. Allergan Recent Development
Table 119. Mayo Clinic Company Details
Table 120. Mayo Clinic Business Overview
Table 121. Mayo Clinic Product
Table 122. Mayo Clinic Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 123. Mayo Clinic Recent Development
Table 124. Bristol-Myers Squibb Company Details
Table 125. Bristol-Myers Squibb Business Overview
Table 126. Bristol-Myers Squibb Product
Table 127. Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 128. Bristol-Myers Squibb Recent Development
Table 129. Takeda Company Details
Table 130. Takeda Business Overview
Table 131. Takeda Product
Table 132. Takeda Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 133. Takeda Recent Development
Table 134. Brainsway Company Details
Table 135. Brainsway Business Overview
Table 136. Brainsway Product
Table 137. Brainsway Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 138. Brainsway Recent Development
Table 139. Lundbeck Company Details
Table 140. Lundbeck Business Overview
Table 141. Lundbeck Product
Table 142. Lundbeck Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 143. Lundbeck Recent Development
Table 144. NeuroStar Company Details
Table 145. NeuroStar Business Overview
Table 146. NeuroStar Product
Table 147. NeuroStar Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 148. NeuroStar Recent Development
Table 149. Otsuka Company Details
Table 150. Otsuka Business Overview
Table 151. Otsuka Product
Table 152. Otsuka Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 153. Otsuka Recent Development
Table 154. VistaGen Therapeutics Company Details
Table 155. VistaGen Therapeutics Business Overview
Table 156. VistaGen Therapeutics Product
Table 157. VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 158. VistaGen Therapeutics Recent Development
Table 159. Silver Oak Health Company Details
Table 160. Silver Oak Health Business Overview
Table 161. Silver Oak Health Product
Table 162. Silver Oak Health Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 163. Silver Oak Health Recent Development
Table 164. NeuroSigma Company Details
Table 165. NeuroSigma Business Overview
Table 166. NeuroSigma Product
Table 167. NeuroSigma Revenue in Depression Treatment Therapy Business (2015-2020) (Million US$)
Table 168. NeuroSigma Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Depression Treatment Therapy Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Treatment device Features
Figure 4. Global Depression Treatment Therapy Market Share by Application: 2020 VS 2026
Figure 5. Seasonal affective disorder (SAD) Case Studies
Figure 6. Major depression Case Studies
Figure 7. Dysthymia disorder Case Studies
Figure 8. Postpartum depression Case Studies
Figure 9. Atypical depression Case Studies
Figure 10. Psychotic depression Case Studies
Figure 11. Bipolar disorder Case Studies
Figure 12. Depression Treatment Therapy Report Years Considered
Figure 13. Global Depression Treatment Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Depression Treatment Therapy Market Share by Regions: 2020 VS 2026
Figure 15. Global Depression Treatment Therapy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Depression Treatment Therapy Market Share by Players in 2019
Figure 18. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Treatment Therapy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Depression Treatment Therapy Revenue in 2019
Figure 20. North America Depression Treatment Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Depression Treatment Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Depression Treatment Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Depression Treatment Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Depression Treatment Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Depression Treatment Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Depression Treatment Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
産後うつ病治療の世界市場（～2026年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Postpartum Depression Treatment Scope and Market Si…- 不安障害・うつ病治療の世界市場（～2026年） Anxiety disorders and depression are treatable, and the vast majority of people can be helped with professional care. Often depression and an anxiety disorder can be treated similarly. In many cases, therapy can be tailored to an individual so that it works to reduce the symptoms of both disorders. …
- 産後うつ病治療薬の世界市場（～2026年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…
- 季節性情動障害の世界市場（～2026年） Seasonal Affective Disorder (SAD) is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people betw…